Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients

Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients

More than three years have passed since the first case, and COVID-19 is still a health concern, with several open issues such as the lack of reliable predictors of a patient’s outcome. Osteopontin (OPN) is involved in inflammatory response to infection and in thrombosis driven by chronic inflammatio...

Full description

Bibliographic Details
Main Authors: Stelvio Tonello, Davide D’Onghia, Daria Apostolo, Erica Matino, Martina Costanzo, Giuseppe Francesco Casciaro, Alessandro Croce, Eleonora Rizzi, Erika Zecca, Anita Rebecca Pedrinelli, Veronica Vassia, Paolo Ravanini, Maria Grazia Crobu, Manuela Rizzi, Raffaella Landi, Luigi Mario Castello, Rosalba Minisini, Gian Carlo Avanzi, Mario Pirisi, Daniele Lilleri, Mattia Bellan, Donato Colangelo, Pier Paolo Sainaghi
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Viruses
Subjects:
Osteopontin (OPN)
COVID-19
SARS-CoV-2
inflammation
biomarker
Online Access:https://www.mdpi.com/1999-4915/15/3/630

Internet

https://www.mdpi.com/1999-4915/15/3/630

Similar Items